Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes
出版年份 2020 全文链接
标题
Circulating MicroRNAs as Prognostic and Therapeutic Biomarkers in Breast Cancer Molecular Subtypes
作者
关键词
-
出版物
Journal of Personalized Medicine
Volume 10, Issue 3, Pages 98
出版商
MDPI AG
发表日期
2020-08-24
DOI
10.3390/jpm10030098
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients
- (2020) Patricia M. M. Ozawa et al. Biomolecules
- Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer
- (2020) Shiva Najjary et al. GENE
- Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction
- (2020) Dharambir Kashyap et al. LIFE SCIENCES
- The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics
- (2020) Diana Bautista-Sánchez et al. Molecular Therapy-Nucleic Acids
- Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2020) Andrew McGuire et al. Cancers
- Expression pattern of microRNAs related with response to trastuzumab in breast cancer
- (2019) Fan Yang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer
- (2019) Peter McAnena et al. BMC CANCER
- Epigenetically altered miR‑193a‑3p promotes HER2 positive breast cancer aggressiveness by targeting GRB7
- (2019) Yiyin Tang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas
- (2019) VIRGINIA VALENTINI et al. ANTICANCER RESEARCH
- Correlation between microRNA-21, microRNA-206 and estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 in breast cancer
- (2019) Yuanwen Chen et al. CLINICAL BIOCHEMISTRY
- Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
- (2019) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating MicroRNAs in Cancer: Potential and Challenge
- (2019) Mengying Cui et al. Frontiers in Genetics
- Refinement of breast cancer molecular classification by miRNA expression profiles
- (2019) Rolf Søkilde et al. BMC GENOMICS
- Serum microRNA-21 predicted treatment outcome and survival in HER2-positive breast cancer patients receiving neoadjuvant chemotherapy combined with trastuzumab
- (2019) Baoquan Liu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNA‐188‐5p promotes apoptosis and inhibits cell proliferation of breast cancer cells via the MAPK signaling pathway by targeting Rap2c
- (2019) Xinying Zhu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inhibition of miRNA‑34a promotes triple negative cancer cell proliferation by promoting glucose uptake
- (2019) Zhen Li et al. Experimental and Therapeutic Medicine
- Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer
- (2019) Maria Amorim et al. Frontiers in Genetics
- Identification of Cell-Free Circulating MicroRNAs for the Detection of Early Breast Cancer and Molecular Subtyping
- (2019) Karen C. B. Souza et al. Journal of Oncology
- Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
- (2019) Andrea Ritter et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miR‐188‐5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer
- (2019) Mei Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression
- (2019) Srikanth Nama et al. Scientific Reports
- Identification of Breast Cancer Subtype Specific MicroRNAs Using Survival Analysis to Find Their Role in Transcriptomic Regulation
- (2019) Michał Denkiewicz et al. Frontiers in Genetics
- An update review of deregulated tumor suppressive microRNAs and their contribution in various molecular subtypes of breast cancer
- (2019) Narges Dastmalchi et al. GENE
- Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients
- (2018) Wenjun Liu et al. Cancer Biomarkers
- Branched rolling circle amplification method for measuring serum circulating microRNA levels for early breast cancer detection
- (2018) Tingting Fan et al. CANCER SCIENCE
- MicroRNAs in regulation of triple-negative breast cancer progression
- (2018) Dominika Piasecka et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
- (2018) Huiping Li et al. Nature Communications
- Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
- (2018) Hao Wang et al. Clinical Epigenetics
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Serum levels of circulating miRNA-21, miRNA-10b and miRNA-200c in triple-negative breast cancer patients
- (2018) Sebastian Niedźwiecki et al. Ginekologia Polska
- MicroRNA-21 as a predictor and prognostic factor for trastuzumab therapy in human epidermal growth factor receptor 2-positive metastatic breast cancer
- (2018) Marwa Badr et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients
- (2018) Solmaz Khalighfard et al. Scientific Reports
- Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial
- (2017) K.C. Aalders et al. EUROPEAN JOURNAL OF CANCER
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
- (2017) Rimi Hamam et al. Cell Death & Disease
- Circulating Cell-free miRNA Expression and its Association with Clinicopathologic Features in Inflammatory and Non-Inflammatory Breast Cancer
- (2016) K Hamdi et al. Asian Pacific Journal of Cancer Prevention
- Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies
- (2016) Julia S. Sisti et al. INTERNATIONAL JOURNAL OF CANCER
- Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes
- (2016) Sasagu Kurozumi et al. JOURNAL OF HUMAN GENETICS
- 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- (2016) Fatima Cardoso et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells
- (2016) Gillian Browne et al. TUMOR BIOLOGY
- Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients
- (2016) Dezheng Huo et al. Oncotarget
- Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer
- (2016) Seema Thakur et al. PLoS One
- microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection
- (2016) Rimi Hamam et al. Scientific Reports
- Therapeutic Use of MicroRNAs in Cancer
- (2015) Alessandra Tessitore et al. Anti-Cancer Agents in Medicinal Chemistry
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
- (2015) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
- (2015) Gloria Bertoli et al. Theranostics
- Epigenetic Silencing of ITGA2 by MiR-373 Promotes Cell Migration in Breast Cancer
- (2015) Wen Ding et al. PLoS One
- Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
- (2015) Corinna Eichelser et al. Oncotarget
- Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial
- (2014) Volkmar Müller et al. BREAST CANCER RESEARCH AND TREATMENT
- A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients
- (2014) K. Kleivi Sahlberg et al. CLINICAL CANCER RESEARCH
- High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2+ Inflammatory Breast Cancer
- (2014) Simone Anfossi et al. PLoS One
- Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer
- (2014) Ailbhe M. McDermott et al. PLoS One
- Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel
- (2014) Qian Li et al. PLoS One
- MicroRNAs in Cancer
- (2013) Gianpiero Di Leva et al. Annual Review of Pathology-Mechanisms of Disease
- Deregulated Serum Concentrations of Circulating Cell-Free MicroRNAs miR-17, miR-34a, miR-155, and miR-373 in Human Breast Cancer Development and Progression
- (2013) C. Eichelser et al. CLINICAL CHEMISTRY
- The current state of breast cancer classification
- (2012) G. Viale ANNALS OF ONCOLOGY
- Circulating MicroRNAs
- (2012) Esther E. Creemers et al. CIRCULATION RESEARCH
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- miRNAs and regulation of cell signaling
- (2011) Atsuhiko Ichimura et al. FEBS Journal
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
- (2011) J. D. Arroyo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)
- (2010) Evan M. Kroh et al. METHODS
- An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers
- (2009) Rachael Natrajan et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models
- (2009) Anna Bergamaschi et al. Molecular Oncology
- Detection of microRNA Expression in Human Peripheral Blood Microvesicles
- (2008) Melissa Piper Hunter et al. PLoS One
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More